[1] 王长虹,吕路线,姚丰菊,等. 河南省精神障碍流行病学调查精神分裂症流行情况分析[J].中华精神科杂志,2020,53(1):23-28. [2] WANG Q J, REN H H, LI C W, et al. Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a 1H MRS study[J].Transl Psychiatry,2022,12(1):116. [3] ONWORDI E C, WHITEHURST T, MANSUR A, et al. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study[J].Transl Psychiatry,2021,11(1):393. [4] PENG W H, TAN Q Y, YU M L, et al. Transcriptome sequencing reveals the potential mechanisms of modified electroconvulsive therapy in schizophrenia[J].Psychiatry Investig,2021,18(5):385-391. [5] OTSUKI K, HAYASHI S, NAGAHAMA M, et al. Favorable outcome after modified electroconvulsive therapy in the perioperative management of a patient with treatment-resistant schizophrenia and a femoral neck fracture[J].J ECT,2021,37(3):e29-e31. [6] 平蕊,谢广贺,汪丽. 急性脑梗死介入术后应用丹红注射液联合乙酰谷酰胺治疗的有效性和安全性[J].中西医结合心脑血管病杂志,2020,18(21):3697-3700. [7] MA M L, HE L P. Electroconvulsive therapy plays an irreplaceable role in treatment of major depressive disorder[J].World J Clin Cases,2022,10(16):5515-5517. [8] 范桂红,何俊,庞高峰,等. 无抽搐电休克疗法对精神分裂症患者的治疗效果和脑内及不同脑区神经递质水平的影响研究[J].中国全科医学,2022,25(3):325-330. [9] 沈含冰,赵海音,陈剑华,等. 中西医针药结合对痰湿阻滞型精神分裂症患者的治疗效果[J].贵州医科大学学报,2021,46(11):1338-1342. [10] 陆晶晶,孙莲芳,张莉. 重复经颅磁刺激治疗对精神分裂症患者阴性症状、认知功能、脑内神经递质及血清炎症因子的影响[J].临床与病理杂志,2022,42(8):1945-1951. [11] 武鸯,曹雍华,张毅. 奥氮平联合无抽搐电休克治疗首发精神分裂症的疗效及对血清炎症因子及BDNF、S100B、GFAP水平的影响[J].临床和实验医学杂志,2021,20(17):1891-1894. [12] 王旭东,武勇法,蔡梦燕,等. 血清皮质醇、5-羟色胺、炎症因子、蛋白因子水平与精神分裂症病情的相关性研究[J].浙江医学,2020,42(24):2641-2644. [13] 张忠良,张集慧,陈波. 精神分裂症外周血中BDNF、MIF、EGF水平及其与认知功能关系[J].蚌埠医学院学报,2022,47(7):866-869. [14] 潘永花,李成雄,王雪. 吸氧联合胞二磷胆碱对精神分裂症患者无抽搐电休克治疗后短时记忆、计算及言语功能的影响[J].神经损伤与功能重建,2022,17(2):120-122.
2024, Vol. 41 
